Filing Details
- Accession Number:
- 0000950170-25-036679
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-10 19:56:13
- Reporting Period:
- 2025-03-06
- Filing Date:
- 2025-03-10
- Accepted Time:
- 2025-03-10 19:56:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1605456 | K Vivek Jayaraman | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-06 | 545,000 | $0.00 | 1,450,828 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-03-06 | 90,486 | $0.00 | 1,541,314 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-03-07 | 33,999 | $1.50 | 1,507,315 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2026, and 66% of the grant vesting on March 12, 2027, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. These RSUs were granted in payment of a portion of the 2024 annual bonus awarded to the Reporting Person and were fully vested upon grant, with no expiration date.
- Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
- Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.445 to $1.54 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
Billionaire Hedge Funds
